Company
Every investor coverage indicates participated in a round Emphasys Medical raised.
Companies Emphasys Medical acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| John McCutcheon | President and CEO (former) | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Emphasys Medical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Cardiac pacing developer EBR Systems has completed a $30 million financing co-led by two Australian investors to finish its clinical trial, and has appointed John McCutcheon as president and chief executive.